{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-071833","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.068372+00:00","generated_at":"2026-05-31T08:05:11.552400+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SS Innovations expands board to 7, appoints Dr. Frederic Moll (Intuitive Surgical co-founder) and Timothy Adams","bullets":["Board expanded from 5 to 7 members; Dr. Frederic Moll appointed as director and non-executive Vice Chairman, effective August 20, 2024.","Dr. Moll co-founded Intuitive Surgical and Auris Health; most recently Chief Development Officer at Johnson & Johnson Medical Devices (2019-2023).","Timothy P. Adams appointed as director; current Regional Operating Officer at Ascension, overseeing high-growth horizontal business units.","Both appointees deemed independent; compensation committee formed with Adams (Chair), Moll, and Dr. S.P. Somashekhar.","Company cites their expertise in robotic surgery and U.S. healthcare as key to advancing FDA approval and market expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-071833","json":"https://secwatch.observer/filing/0001213900-24-071833.json","markdown":"https://secwatch.observer/filing/0001213900-24-071833.md","text":"https://secwatch.observer/filing/0001213900-24-071833.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/0001213900-24-071833-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/ea0212126-8k_ssinnov.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:05:11.552400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2090cbedb3","claim":"Timothy P. Adams was appointed as Director at SS Innovations International, Inc..","evidence_excerpt":"Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/0001213900-24-071833-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a12f3e7172","claim":"Dr. Frederic Moll was appointed as Director and Non-executive Vice Chairman at SS Innovations International, Inc..","evidence_excerpt":"Effective August 20, 2024, SSi expanded its board of directors from five (5) to seven (7) members and Dr. Frederic Moll and Timothy P. Adams were appointed as directors to fill the newly created vacancies on the board. In addition, Dr. Moll was appointed as non-executive Vice Chairman of the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/0001213900-24-071833-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Non-executive Vice Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}